Amr R. Ibrahim, Richard E. Clark, Tessa L. Holyoake, Jenny Byrne, Pat Shepherd, Jane F. Apperley, Dragana Milojkovic, Richard Szydlo, John Goldman and David Marin (2011) “Second-generation tyrosine kinase inhibitors improve the survival of patients with chronic myeloid leukemia in whom imatinib therapy has failed”, Haematologica. Pavia, Italy, 96(12), pp. 1779-1782. doi: 10.3324/haematol.2011.049759.